Document is current

Any future updates will be listed below

The Efficacy and Safety of Adding Chlorpromazine to Atazanavir/Ritonavir Regimen in the Treatment of Moderate COVID-19 Patients, a Randomized Double-blind Clinical Trial

Crossref DOI link: https://doi.org/10.32598/PBR.9.3.1084.1

Published Online: 2023-09-01

Update policy: https://doi.org/10.32598/nsp.crossmark-policy

About CrossMark